Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by CohBar, Inc.

CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
From CohBar, Inc.
Via Business Wire
Tickers CWBR
CohBar Reports Second Quarter 2023 Financial Results
From CohBar, Inc.
Via GlobeNewswire
Tickers CWBR
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
From CohBar, Inc.
Via GlobeNewswire
Tickers CWBR
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
From CohBar, Inc.
Via GlobeNewswire
Tickers CWBR
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
From CohBar, Inc.
Via GlobeNewswire
Tickers CWBR
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
From CohBar, Inc.
Via GlobeNewswire
Tickers CWBR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.